121 related articles for article (PubMed ID: 17687202)
1. [Long-term results of S-1 administration as adjuvant chemotherapy for advanced head and neck cancer].
Tsukuda M; Kida A; Fujii M; Kono N; Yoshihara T; Hasegawa Y; Sugita M
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1215-25. PubMed ID: 17687202
[TBL] [Abstract][Full Text] [Related]
2. [Adjuvant chemotherapy with S-1 for advanced head and neck carcinoma].
Tsukuda M; Ishitoya J; Mikami Y; Matsuda H; Katori H; Horiuchi C; Taguchi T; Yoshida T; Toth G
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():172-8. PubMed ID: 16897997
[TBL] [Abstract][Full Text] [Related]
3. S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy.
Yokota T; Onozawa Y; Boku N; Hamauchi S; Tsushima T; Taniguchi H; Todaka A; Machida N; Yamazaki K; Fukutomi A; Yasui H
Jpn J Clin Oncol; 2011 Dec; 41(12):1351-7. PubMed ID: 21980053
[TBL] [Abstract][Full Text] [Related]
4. Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer.
Tsukuda M; Kida A; Fujii M; Kono N; Yoshihara T; Hasegawa Y; Sugita M;
Br J Cancer; 2005 Oct; 93(8):884-9. PubMed ID: 16189518
[TBL] [Abstract][Full Text] [Related]
5. [Adjuvant chemotherapy with S-1 for head and neck carcinoma].
Terao K; Saito K; Mori K; Murata K
Gan To Kagaku Ryoho; 2008 Mar; 35(3):425-9. PubMed ID: 18347390
[TBL] [Abstract][Full Text] [Related]
6. [A case report of cancer of the lip--complete response by a neo-adjuvant chemotherapy using a novel method of TS-1 administration].
Nakanome A; Shiga K; Sagai S; Ogawa T; Kobayashi T
Gan To Kagaku Ryoho; 2006 Mar; 33(3):353-6. PubMed ID: 16531717
[TBL] [Abstract][Full Text] [Related]
7. [Late phase II study of S-1 in patients with advanced head and neck cancer].
Inuyama Y; Kida A; Tsukuda M; Kohno N; Satake B;
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1381-90. PubMed ID: 11681245
[TBL] [Abstract][Full Text] [Related]
8. [A randomized controlled trial to evaluate the effect of adjuvant oral fluoropyrimidine derivative therapy after curative resection for stage II/III rectal cancer-adjuvant chemotherapy trial of S-1 for rectal cancer (ACTS-RC):].
Oki E; Kakeji Y; Yoshida R; Ikeda K; Nishida K; Koga T; Egashira A; Tokunaga E; Morita M; Baba H; Maehara Y
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():138-43. PubMed ID: 16897990
[TBL] [Abstract][Full Text] [Related]
9. [A case of advanced oral squamous cell carcinoma responding to concurrent radiotherapy with S-1].
Harada K; Kawashima Y; Uchida D; Yoshida H
Gan To Kagaku Ryoho; 2007 May; 34(5):745-7. PubMed ID: 17496449
[TBL] [Abstract][Full Text] [Related]
10. [Early phase II study of S-1 in patients with advanced head and neck cancer. S-1 Cooperative Study Group (Head and Neck Working Group)].
Inuyama Y; Kida A; Tsukuda M; Kohno N; Satake B
Gan To Kagaku Ryoho; 1998 Jul; 25(8):1151-8. PubMed ID: 9679577
[TBL] [Abstract][Full Text] [Related]
11. [Two cases of head and neck squamous cell carcinoma in which S-1 administration resulted in long-term sustained QOL].
Shimane T; Mori T; Ono T; Monden T; Furuya A; Kobayashi S; Sanbe T; Suzaki H
Gan To Kagaku Ryoho; 2009 Jul; 36(7):1141-4. PubMed ID: 19620804
[TBL] [Abstract][Full Text] [Related]
12. [A case of neck metastasis from hypopharyngeal carcinoma successfully treated with TS-1].
Kajikawa H; Nario K; Miyahara H
Gan To Kagaku Ryoho; 2004 Apr; 31(4):631-4. PubMed ID: 15114715
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
Kubota A; Nakatani E; Tsukahara K; Hasegawa Y; Takemura H; Terada T; Taguchi T; Nagahara K; Nakatani H; Yoshino K; Higaki Y; Iwae S; Beppu T; Hanamure Y; Tomita K; Kohno N; Kawabata K; Teramukai S; Fujii M;
PLoS One; 2018; 13(6):e0198391. PubMed ID: 29883463
[TBL] [Abstract][Full Text] [Related]
14. Outpatient oral chemotherapy with S-1 for unresectable or distant metastatic head and neck cancer.
Maeda M; Yamashita T; Matsunobu T; Araki K; Tomifuji M; Shiotani A
Anticancer Res; 2013 Aug; 33(8):3285-9. PubMed ID: 23898093
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
[TBL] [Abstract][Full Text] [Related]
16. [Adjuvant chemotherapy with TS-1 for head and neck cancer--side effect of two-week application followed by one-week rest regimen].
Itoi A; Takashima M; Ishimasa H; Murata H; Tomoda K
Gan To Kagaku Ryoho; 2006 May; 33(5):617-20. PubMed ID: 16685159
[TBL] [Abstract][Full Text] [Related]
17. [Clinical efficacy of administration with S-1 alone for head and neck carcinoma].
Tsukuda M; Ishitoya J; Mikami Y; Matsuda H; Katori H; Horiuchi C; Taguchi T; Yoshida T; Toth G
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():144-9. PubMed ID: 16897991
[TBL] [Abstract][Full Text] [Related]
18. [Results of chemotherapy in head and neck cancer patients with residual or recurrent tumors after initial treatment].
Katsuno M; Watanabe N; Sugio Y; Tachibana S; Tani Y; Sato N; Zusho H
Gan To Kagaku Ryoho; 2010 Nov; 37(11):2109-13. PubMed ID: 21084809
[TBL] [Abstract][Full Text] [Related]
19. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
Choi YJ; Chung JS; Shin HJ; Cho GJ; Wang SG; Lee BJ; Cho BM; Joo YD; Sohn CH
J Laryngol Otol; 2008 Aug; 122(8):848-53. PubMed ID: 18047761
[TBL] [Abstract][Full Text] [Related]
20. Outpatient chemotherapy with S-1 for recurrent head and neck cancer.
Yamashita T; Shinden S; Watabe T; Shiotani A
Anticancer Res; 2009 Feb; 29(2):577-81. PubMed ID: 19331206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
